Thank you for making Combination Products 2025 incredible!
Agenda
The Strategic Committee is working diligently on the 2026 program line-up to ensure the highest quality discussions, knowledge exchange, and collaboration opportunities. Here is a sneak peek at what to expect this November.
Preconference Workshop: Navigating Industry Trends: Hot Topics, Regulatory Best Practices, and Drug Delivery Strategies (Monday, November 16; additional fee required)
The Solutions Exchange: Talent and Organizational Structure for a Combination Products Organization
From the Desk of the Office of Combination Products – Strategic Priorities
Evolving European Union Legislation, Regulation, and Policy for Integral Drug-Device Combinations
Clinical Investigations for Combined Use Systems (2026 update)
The New Frontier: Evolving Pharma Capabilities for Standalone Devices
FDA and Industry Insights: QMSR Impacts on Combination Product Design, Development & Risk and How to Prepare for Compliance
Global Updates for Drug Delivery
Timely Changes: FDA Expectations and Industry Strategies for Combination Products
Digital Innovation integrated with advanced On-Body Drug Delivery Systems (OBDS)
10 Years Since US Combination Product cGMP Regulations: Reflections on Requirements, Expectations, and Enforcement
“The event was so valuable, as always. If I can only attend one event in a given year, this is the one that I prioritize.”
Suzette Roan
Associate VP, Head of GRA Devices, Sanofi
